![Anish Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anish Patel
Fondateur chez
ENLIVEN THERAPEUTICS, INC.
Fortune : 14 M $ au 31/08/2026
Profil
Anish Patel is the founder of Enliven Therapeutics, Inc., founded in 2019, and holds the title of Chief Operating Officer since 2023.
Dr. Patel is also the founder of Enliven Therapeutics, Inc...
Dr. Patel worked at AbbVie Stemcentrx LLC from 2013 to 2016 as Senior Director-Field Medical & Marketing.
Dr. Patel worked at Stemcentrx, Inc. from 2016 to 2019 as Head-Medical Affairs.
Dr. Patel earned a doctorate from the University of Michigan and completed undergraduate studies at the University of Illinois At Urbana–Champaign.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/02/2026 | 235 011 ( 0,32 % ) | 14 M $ | 31/08/2026 |
Postes actifs de Anish Patel
| Sociétés | Poste | Début |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Fondateur | 01/06/2019 |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Fondateur | - |
Anciens postes connus de Anish Patel
| Sociétés | Poste | Fin |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Corporate Officer/Principal | 01/04/2019 |
AbbVie Stemcentrx LLC | Sales & Marketing | 01/07/2016 |
Formation de Anish Patel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie Stemcentrx LLC | |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Health Technology |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
